Searched for
ASHISH ANVEKAR
Aurobindo unit, Evive Biotech ink licensing pact to commercialise CIN treatment product in USNeutropenia is a common side-effect of chemotherapy and is a condition characterised by low levels of neutrophils, a type of white blood ce...- Aurobindo acquires 7 oncology drugs from spectrum for $300 millionNasdaq-listed Spectrum Pharmaceuticals has carved out its commercial business inclusive of seven marketed oncology injectable products, int...
- Ranbaxy launches acne treatment capsules in the US marketRanbaxy Laboratories Inc has announced the launch of Absorica capsules in the strengths of 25 mg and 35 mg in the US market.
- Ranbaxy launches anti-acne drug in the US marketAccording to an analyst, the launch of Absorica would greatly benefit Ranbaxy as there are only 2-3 players currently selling the product i...
Load More